The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis
Open Access
- 2 August 2011
- journal article
- research article
- Published by Hindawi Limited in Multiple Sclerosis International
- Vol. 2011, 1-10
- https://doi.org/10.1155/2011/271321
Abstract
Objective. Examine the impact of comorbid depression on adherence to disease-modifying therapy (DMT) for multiple sclerosis (MS).Methods. A retrospective database was used to identify patients with MS treated with a DMT. Patients with MS and comorbid depression were matched to patients with MS only. Adherence to DMT was proxied by the medication possession ratio (MPR) and multivariate regressions were used to examine the association between comorbid depression and adherence to DMT.Results. Patients with comorbid depression had a 10 point lower MPR () and were less likely to achieve a MPR of at least 80% (odds ratio; 95% confidence interval (CI) 0.42–0.74) than those without depression. While treatment with an antidepressant generally had no significant impact on the likelihood of achieving an MPR threshold of 80% (; 95% CI 0.50–3.48), adherence to antidepressant therapy guidelines were associated with improved adherence to DMT therapy.Conclusions. MS patients with comorbid depression were approximately half as likely to be adherent to their DMT relative to patients with MS without depression. Although treatment with antidepressant therapy generally did not improve the likelihood of adherence, treatment with antidepressants for at least 6 months was associated with better adherence to DMT.
Keywords
This publication has 40 references indexed in Scilit:
- The association of depression with adherence to antihypertensive medications: a systematic reviewJournal of Hypertension, 2010
- Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancerBreast Cancer Research and Treatment, 2010
- Problems of Nonadherence in Cardiology and Proposals to Improve OutcomesThe American Journal of Cardiology, 2010
- Economic Burden of Multiple SclerosisPharmacoEconomics, 2010
- Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 DiabetesPostgraduate Medicine, 2010
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Depression and Medication Adherence in Outpatients With Coronary Heart DiseaseArchives of Internal Medicine, 2005
- Depressive Symptoms and Mortality Two Years After Coronary Artery Bypass Graft Surgery (CABG) in MenPsychosomatic Medicine, 2003
- A comprehensive assessment of the cost of multiple sclerosis in the United StatesMultiple Sclerosis Journal, 1998
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992